Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI)
Introduction to the Test
The Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) test is a cutting-edge diagnostic tool used in oncology to evaluate the genetic mutations present in tumor tissues. This test is essential for understanding the genetic profile of cancers, which can guide treatment decisions and improve patient outcomes. By measuring TMB and assessing MSI, healthcare providers can better understand a tumor’s behavior and its potential response to immunotherapy.
What the Test Measures
The Oncomine TMB and MSI test detects the number of mutations in the tumor DNA (TMB) and evaluates the stability of microsatellite regions (MSI). High TMB levels may indicate a greater likelihood of response to certain immunotherapies, while MSI status can signal specific types of cancer that may benefit from targeted treatments.
Who Should Consider This Test
This test is recommended for patients exhibiting symptoms of cancer or those with risk factors such as:
- Family history of cancer
- Previous cancer diagnoses
- Unexplained weight loss
- Persistent fatigue
- Changes in bowel or bladder habits
If you have concerns about your cancer risk or are seeking personalized treatment options, consider discussing this test with your healthcare provider.
Benefits of Taking the Test
- Identifies specific genetic mutations that can influence treatment decisions.
- Helps in predicting response to immunotherapy.
- Facilitates personalized treatment plans based on genetic profiles.
- Enhances understanding of cancer progression and prognosis.
Understanding Your Results
Results from the Oncomine TMB and MSI test will provide insights into the genetic mutations present in your tumor. A high TMB may indicate a better response to immunotherapy, while MSI status can help identify specific treatment pathways. It is crucial to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) | 1,050,000 NGN | 1,400,000 NGN |
Booking the Test
To book the Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) test, please ensure you have a Doctor’s prescription. Note that prescriptions are not required for surgery and pregnancy cases or for individuals planning to travel abroad. For further assistance, feel free to contact us at +2348077798758.
Turnaround time for results is approximately 2-3 weeks, and the sample type required includes tumor tissue and peripheral blood using paraffin embedded tissue blocks and an EDTA Vacutainer (3 ml).
Take a proactive step in managing your health. Book your test today!
